跳至主要内容
临床试验/NCT04379193
NCT04379193已完成不适用

Ambulatory Neuroproprioceptive Facilitation and Inhibition Physical Therapy Does Not Modulate Serum Level of Neuroactive Steroids

Charles University, Czech Republic0 个研究点目标入组 63 人开始时间: 2015年5月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
63
主要终点
serum level of neuroactive steroids

研究概览

简要总结

This study describes modulation of neuroproprioceptive facilitation and inhibition physical therapy on serum level of neuroactive steroids in multiple sclerosis.

详细描述

In the parallel group, single blind, randomized controlled trial, participant underwent two kinds of neuroproprioceptive PT (MPAT and VRL). At baseline and after the end of the two months' therapeutic program, a blinded assessor evaluated clinical outcomes and data from serum level.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • prevailed spastic paraparesis, stable clinical status and treatment in the preceding 3 months determined by neurologist,
  • Expanded Disability Status Scale score (EDSS) max. 7.5

排除标准

  • other neurological disease or conditions disabling movement

结局指标

主要结局

serum level of neuroactive steroids

时间窗: 2 months

cortisol, cortisone, 7 alfa-OH-DHEA, 7 beta-OH-DHEA, 7 oxo- oxo-DHEA, DHEA

次要结局

  • Berg Balance Scale, BBS outcomes(2 months)
  • Paced Auditory Serial Addition Test(2 months)
  • the 29-item Multiple Sclerosis Impact Scale, MSIS -29(2 months)
  • Modified Fatigue Impact Scale(2 months)

研究者

发起方
Charles University, Czech Republic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Kamila Řasová

assoc. prof. Kamila Řasová, Ph.D.

Charles University, Czech Republic

相似试验

Physical Therapy and Neuroactive Steroids Therapy... | 临床试验